Our overall goal is to study hepatitis B virus (HBV) gene expression in animal cells and to determine its role in chronic liver disease and hepatocellular carcinoma. Studies will be divided into 3 general components 1) descriptive viral pathophysiology, 2) viral molecular biology, and 3) viral cell biology. These studies require a variety of materials and approaches, many of which have been made possible by recent availability of recombinant DNA molecules containing HBV sequences. Our use of labelled cloned HBV-DNA to identify and characterize HBV sequences in a human hepatocellular carcinoma line (PLC/PRF/5 and liver biopsy specimens from chimpanzee HBV carriers indicates the feasibility of this project. In PLC/PRF/5 cells, we observed integrated HBV-DNA and three RNAs with viral sequences by restriction enzyme and molecular hybridization analysis. Experiments will be performed to determine in what percentage of hepatomas in which HBV-sequences are present, are these sequences integrated into the host genome, and when does integration occur? We would also like to identify and characterize mRNAs coding for specific HBV proteins, map these mRNAs on the viral genome, and study the viral transcription mechanism. This will be accomplished by pulse labelling of HBV-RNAs in vivo and by studying in vitro transcription of cloned HBV-DNAs in a DNA-dependent HeLa cellular extract. The latter system will also be used to identfy the promoter site(s) for HBV transription. By using recombinant clones of PLC/PRF/5 HBV-DNA containing host flanking regions, we will characterize HBV and host sequences surrounding the integration sites in the PLC/PRF/5 cell line and in human hepatocellular carcinomas. RNA transcripts containing both host and viral sequences will also be studied in the PLC/PRF/5 cell line. Finally, cellular transformation experiments will be performed to determine whether HBV-DNA is oncogenic in tissue culture and, is so, what portion of the HBV gene confers oncogenicity. These experiments will involve direct transformation of eukaryotic cells by HBV-DNA, restriction fragments of HBV-DNA and cloned integrated HBV-DNA from the PLC/PRF/5 cell line. These studies will, therefore, use multiple approaches to study the influence of HBV-genes on the molecular properties of liver cells and the role of HBV in chronic liver disease and primary liver cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA032605-04
Application #
3170508
Study Section
Virology Study Section (VR)
Project Start
1982-02-01
Project End
1987-01-31
Budget Start
1985-02-01
Budget End
1986-01-31
Support Year
4
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Aragona, E; Burk, R D; Ott, M et al. (1996) Cell type-specific mechanisms regulate hepatitis B virus transgene expression in liver and other organs. J Pathol 180:441-9
Wands, J R; Liang, T J; Blum, H E et al. (1992) Molecular pathogenesis of liver disease during persistent hepatitis B virus infection. Semin Liver Dis 12:252-64
Mutchnick, M G; Appelman, H D; Chung, H T et al. (1991) Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial. Hepatology 14:409-15
Tur-Kaspa, R; Teicher, L; Laub, O et al. (1990) Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription. J Virol 64:1821-4
Gupta, S; Chowdhury, N R; Jagtiani, R et al. (1990) A novel system for transplantation of isolated hepatocytes utilizing HBsAg-producing transgenic donor cells. Transplantation 50:472-5
Tur-Kaspa, R; Shaul, Y; Moore, D D et al. (1988) The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 167:630-3
Raimondo, G; Burk, R D; Lieberman, H M et al. (1988) Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma. Virology 166:103-12
Hadziyannis, S; Raimondo, G; Papaioannou, C et al. (1987) Expression of pre-S gene-encoded proteins in liver and serum during chronic hepatitis B virus infection in comparison to other markers of active virus replication. J Hepatol 5:253-9
Shafritz, D A; Hadziyannis, S J (1987) Molecular pathophysiology of persistent hepatitis B virus infection in relation to chronic liver disease and primary hepatocellular carcinoma. Monogr Pathol :136-52
Lieberman, H M; Tung, W W; Shafritz, D A (1987) Splenic replication of hepatitis B virus in the chimpanzee chronic carrier. J Med Virol 21:347-59

Showing the most recent 10 out of 16 publications